More recently, an adiponectin agonist reversed liver fibrosis in mice by attenuating the expression of the fibrogenesis markers α-SMA, TGF-β1, CTGF, and tissue inhibitor of metalloproteinase I (TIMP1) [56]. Here, ADIPOQ is linked to Hepatic fibrosis.